ONYX-015, for example, as an E1B gene-defective adenovirus, was the first genetically engineered OV to be tested in humans; it would selectively replicate and destroy tumor cells carrying mutations of the p53 tumor suppressor gene. Here, TP53 is linked to neoplasm.